GlassScriptPhysician profile
Elphida Ayvazian
NPI 1558558890
$6,379.44
in general payments reported to CMS, 2019-2025
7 companies · $747 in 2025
The $747 reported for 2025 was more than what 84% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $461 · 2020: $334 · 2021: $125 · 2022: $631 · 2023: $3,133 · 2024: $948 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,500 · Entertainment: $1,352 · Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,500.00 |
| Entertainment | $1,352.28 |
| Food and Beverage | $975.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $4,548.96 | 2019-2025 | |
| Nobel Biocare USA | $736.14 | 2019-2023 | Nobelactive |
| Ivoclar Vivadent, INC. | $422.69 | 2019-2024 | |
| Straumann USA LLC | $372.42 | 2022-2024 | |
| Align Technology, INC. | $263.18 | 2020-2023 | Itero Element 5d Plus, Invisalign System - Moderate |
| Dentsply Sirona INC | $19.24 | 2025 | Steri-Mate |
| Orapharma, A Division of Bausch Health US, LLC | $16.81 | 2024 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elphida Ayvazian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.